Health Logic Interactive Provides Product Update for MATLOC 1 and Update on Its FDA Pre-Submission Meeting

CALGARY, AB, Aug. 30, 2021 /CNW/ – Health Logic Interactive Inc. (“Health Logic” or the “Company“) (TSXV: CHIP.H)(OTCPK: CHYPF), is pleased to announce its second update to its digital diagnostic device MATLOC 1. MATLOC 1 is the Company’s proprietary diagnostic platform technology in development for the testing of different biomarkers, with a current focus on the urine-based biomarkers albumin and creatinine … Read more

Health Logic Interactive Signs Non-Binding Letter of Intent With US Medical Device Company to Sell Wholly Owned Operating Subsidiary

CALGARY, AB, Aug. 9, 2021 /PRNewswire/ – Health Logic Interactive Inc. (“Health Logic” or the “Company“) (TSXV: CHIP.H) (OTCPK: CHYPF) is pleased to announce it has signed, on August 1, 2021, a non-binding letter of intent to sell its wholly owned operating subsidiary, My Health Logic Inc. (“My Health Logic“) to Marizyme, Inc. (“Marizyme“), a Nevada medical device company publicly traded on the OTCQB (the … Read more

Health Logic Interactive Provides Update on Anticipated Pre-Submission Meeting with FDA for MATLOC 1

CALGARY, AB, July 12, 2021 /CNW/ – Health Logic Interactive Inc. (“Health Logic” or the “Company“) (TSXV: CHIP.H) (OTCPK: CHYPF), is pleased to announce its continued progress towards an 510(k) pre-submission meeting with the United States Food and Drug Administration (the “FDA“) for its diagnostic screening device MATLOC 1 that is anticipated to occur in September 2021 (the “Pre-Submission Meeting”). An FDA 510(k) pre-submission meeting … Read more

Health Logic Interactive Provides Product Update for MATLOC 1 Digital Diagnostic Device

CALGARY, AB, July 7, 2021 /CNW/ – Health Logic Interactive Inc. (“Health Logic” or the “Company“) (TSXV: CHIP.H)(OTCPK: CHYPF), is pleased to announce its first update to our digital diagnostic device MATLOC 1. MATLOC 1 is the Company’s proprietary diagnostic platform technology in development for the testing of different biomarkers, with a current focus on the biomarkers albumin and creatinine for … Read more

Health Logic Interactive Receives Letter of Support from the Director of the Kidney and Blood Pressure Center at Tufts Medical Center

CALGARY, AB, June 29, 2021 /CNW/ – Health Logic Interactive Inc. (“Health Logic” or the “Company“) (TSXV: CHIP.H) (OTCPK: CHYPF), is pleased to announce its wholly-owned operating subsidiary, My Health Logic Inc. (“My Health Logic“), has received a letter of support for the Company’s chronic kidney disease (CKD) technology from Lesley A. Inker, M.D. MS.  Dr. Inker is the Director of the Kidney and Blood … Read more

Health Logic Interactive Announces Proof-of-Concept Test Results and Advancement of its Lab-on-Chip Technology

CALGARY, AB, June 14, 2021 /CNW/ – Health Logic Interactive Inc. (“Health Logic” or the “Company“) (TSXV: CHIP.H)(OTCPK: CHYPF) is pleased to report positive preliminary proof-of-concept test results of its first urine creatinine chip prototype (uC-Chip beta version), which successfully validated the clinically relevant detection range. In parallel to further optimizing and validating the uC-Chip beta version, the Company’s … Read more

Health Logic Interactive Announces Appointment of Scientific Advisory Board Members and First Virtual Meeting

CALGARY, AB, June 9, 2021 /CNW/ – Health Logic Interactive Inc. (“Health Logic” or the “Company“) (TSXV: CHIP.H) (OTCPK: CHYPF) is pleased to announce the addition of new members to its Scientific Advisory Board (“SAB“) including nephrology specialists Dr. Adeera Levin from the University of British Columbia, Dr. Lesley Inker of Tufts Medical Center, and Dr. Susan Quaggin of Northwestern University. Drs. Levin, Inker and … Read more

Health Logic Interactive Announces the Establishment of Professorship in Lab-on-Chip Innovations and Grant of Options

CALGARY, AB, May 31, 2021 /CNW/ – Health Logic Interactive Inc. (“Health Logic” or the “Company“) (TSXV.CHIP.H) (OTCPK: CHYPF),  is pleased to announce the establishment of a professorship in lab-on-chip innovations at a leading Canadian University. (the “Professorship“). The Professorship will advance a quality research program focused on the innovation and development of lab-on-chip technologies. The Professorship will take … Read more

Health Logic Interactive Receives Letter of Support from the Chief of the Division of Nephrology at Johns Hopkins University School of Medicine

CALGARY, AB, May 26, 2021 /CNW/ – Health Logic Interactive Inc. (“Health Logic” or the “Company“) (TSXV: CHIP.H)(OTCPK: CHYPF), is pleased to announce its wholly-owned operating subsidiary, My Health Logic Inc. (“My Health Logic“), has received a letter of support on the Company’s chronic kidney disease (CKD) technology from nephrologist Chirag R. Parikh, MD, PhD Director, Division of Nephrology at Johns Hopkins University School of Medicine. … Read more

Health Logic Interactive Letter to Shareholders

Dear Shareholders of Health Logic, This is our first letter to the shareholders of Health Logic Interactive Inc.  As your CEO, I intend to communicate to you at least quarterly with respect to the state of our business, our significant milestones and achievements, our challenges, our goals, and any new material additions to our organization. I am extremely … Read more